Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches
F Salari, M Shahjahani, S Shahrabi, N Saki - Medical Oncology, 2014 - Springer
After advances in experimental and clinical testing, minimal residual disease (MRD) assay
results are considered a determining factor in treatment of acute lymphoblastic leukemia …
results are considered a determining factor in treatment of acute lymphoblastic leukemia …
[HTML][HTML] The value of detecting immunoglobulin gene rearrangements in the diagnosis of B-cell lymphoma
C Lu, QY He, W Zhu, CY Fu, JH Zhou, YG Tao, S Liu… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Objective To discuss the clinical value of immunoglobulin gene rearrangements in the
diagnosis of B-cell lymphoma. Methods A total of 209 cases of B-cell lymphomas and 35 …
diagnosis of B-cell lymphoma. Methods A total of 209 cases of B-cell lymphomas and 35 …
Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp
Background: Multidrug resistance is one of the major causes of treatment failure in pediatric
acute lymphoblastic leukemia (ALL), and SORCIN is an intracellular calcium modulator …
acute lymphoblastic leukemia (ALL), and SORCIN is an intracellular calcium modulator …
Monitoring immunoglobulin heavy chain and T‑cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid …
L Zhong, J Chen, X Huang, Y Li… - Oncology …, 2018 - spandidos-publications.com
The present study aimed to examine whether monoclonal immunoglobulin heavy chain
(IGH) or T‑cell receptor (TCR) gene rearrangement in cell‑free DNA (cfDNA) may be used for …
(IGH) or T‑cell receptor (TCR) gene rearrangement in cell‑free DNA (cfDNA) may be used for …
Forty‐nine cases of acute lymphoblastic leukaemia/lymphoma in pleural and pericardial effusions: a cytological‐histological correlation
J Li, W Zhang, W Wang, Y Jiang, S Zhao, W Liu… - …, 2018 - Wiley Online Library
Introduction Acute lymphoblastic leukaemia/lymphoma (ALL/LBL) is an aggressive entity of
precursor lymphoid neoplasm and may cause malignant serous effusion (SE). The current …
precursor lymphoid neoplasm and may cause malignant serous effusion (SE). The current …
Prognostic value and clinical significance of TCR rearrangements for MRD monitoring in ALL patients
M Kavianpur, M Shahjahani, K Jaseb, S Kasar… - Comparative Clinical …, 2017 - Springer
Acute lymphoblastic leukemia is a hematological malignancy of lymphoid progenitor cells
associated with excessive proliferation of lymphocytes, and lymphocyte markers can be …
associated with excessive proliferation of lymphocytes, and lymphocyte markers can be …
Mature T-and NK-Cell Neoplasms
PC Tsang - Practical Oncologic Molecular Pathology: Frequently …, 2021 - Springer
With a few exceptions, mature T-and NK-cell leukemias/lymphomas are aggressive
neoplasms. They tend to be challenging to diagnose due to their uncommon occurrences …
neoplasms. They tend to be challenging to diagnose due to their uncommon occurrences …
[PDF][PDF] Monoclonal pattern of T-Lymphocytes and B-Lymphocytes receptors gene rearrangement in Acute Lymphocytic Leukaemia in Basrah.
NS Al-Ammar, H Kreyenberg… - Onkologia i …, 2023 - researchgate.net
CT Paediatrics clinicians face a problem in evaluation of chemotherapy treatment used for
Acute Lymphoblastic Leukaemia (ALL) patients in Iraq. They need an accurate test to …
Acute Lymphoblastic Leukaemia (ALL) patients in Iraq. They need an accurate test to …
Caracterização molecular dos rearranjos gênicos de imunoglobulinas e receptores de células T em pacientes com leucemia linfoide aguda
IAS Leal - 2016 - repositorio.ufsm.br
AUTORA: ISABEL AGNE SOUZA LEAL ORIENTADORA: ROSMARI HÖRNER Local e Data
da Defesa: Santa Maria, 22 de janeiro de 2016. A Leucemia Linfoide Aguda (LLA) é a causa …
da Defesa: Santa Maria, 22 de janeiro de 2016. A Leucemia Linfoide Aguda (LLA) é a causa …